Balboa Wealth Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$948K Buy
2,187
+83
+4% +$25.2K 0.13% 135
2026
Q1
$450K Sell
2,104
-630
-23% -$141K 0.08% 218
2025
Q4
$468K Buy
+2,734
New +$425K 0.08% 203
2024
Q3
Sell
-2,820
Closed -$300K 360
2024
Q2
$300K Sell
2,820
-1,110
-28% -$106K 0.08% 191
2024
Q1
$382K Buy
3,930
+640
+19% +$56.3K 0.11% 137
2023
Q4
$258K Sell
3,290
-1,040
-24% -$70.9K 0.09% 180
2023
Q3
$271K Sell
4,330
-140
-3% -$9.2K 0.1% 173
2023
Q2
$287K Sell
4,470
-2,370
-35% -$134K 0.1% 169
2023
Q1
$363K Buy
6,840
+1,560
+30% +$76.6K 0.14% 139
2022
Q4
$222K Buy
+5,280
New +$221K 0.1% 199

Other funds holding LRCX

Balboa Wealth Partners's LRCX Position: Q2 2026 in Review

Balboa Wealth Partners increased its Lam Research (LRCX) stake by 3.9% in Q2 2026, buying an estimated $25.2K and bringing the position to 2,187 shares worth $948K. The position accounts for 0.13% of the portfolio, ranked #135.

Balboa Wealth Partners first reported a position in LRCX in Q4 2022 and has held it in 10 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Balboa Wealth Partners held 2,187 shares of Lam Research worth $948K as of Q2 2026.
  • Balboa Wealth Partners bought 83 Lam Research shares in Q2 2026, an estimated $25.2K.
  • Lam Research made up 0.13% of Balboa Wealth Partners's portfolio in Q2 2026, its #135 holding.
  • Balboa Wealth Partners first reported a position in Lam Research in Q4 2022 and has held it in 10 quarters since.
  • 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Balboa Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.